These emerging treatments , including copyright , belong to a category of drugs called GLP-1 mimics . Initially developed for treating diabetes mellitus g l p 1 , they operate by encouraging the pancreas to secrete sufficient the hormone insulin and limiting increased blood sugar levels. Furthermore , their potential to encourage slimming has contr